权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Comparison of kidney function measurement methods in the community

社区肾功能测量方法比较

基本信息

批准号：
8139916
负责人：
ANDREW David RULE
金额：
$ 13.77万
依托单位：
MAYO CLINIC ROCHESTER
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-09-01 至 2012-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8139916
关键词：
Address Adult Affect Age Albuminuria American Appointment Arterial Disorder Attention Award Biometry Cardiovascular Diseases Centers for Disease Control and Prevention (U.S.)Cessation of life Chronic Kidney Failure Classification Clinic Clinical Research Collection Communities Creatinine Creatinine clearance measurement Cross-Sectional Studies Data Development Diabetes Mellitus Dialysis procedure Diet Modification Doctor of Medicine Early Diagnosis Early treatment Environment Epidemiology Equation Excision General Population Glomerular Filtration Rate Gold Grant Hypertension Individual Individual Differences Inflammation Intake Intervention Iothalamate Joints Kidney Kidney Diseases Kidney Failure Knowledge Laboratories Lead Longitudinal Studies Master&apos s Degree Measurement Measures Medicine Mentors Mentorship Metabolic Methods Muscle Proteins Nephrology Patients Peer Review Persons Population Positioning Attribute Prevalence Prevention strategy Race Renal function Research Research Personnel Resources Risk Risk Factors Sampling Serum Societies Staging Study of serum Surrogate Markers Testing Training Transplantation Tubular formation United States Urine Validation Work base cardiovascular disorder risk cardiovascular risk factor clinical practice cohort community setting coronary artery calcification disorder prevention disorder risk genetic epidemiology improved muscle form post gamma-globulins prevent professor programs sex symposium treatment strategy wasting

项目摘要

DESCRIPTION (provided by applicant): Project Summary: The candidate is a nephrologist starting a staff position at the Mayo Clinic on July 1st, 2006. During the past 4 years as a nephrology trainee, the candidate obtained a Master's degree in Clinical Research, first-authored 10 peer-reviewed articles, and received institutional (T32) and individual (F32) National Research Awards. His expertise in the epidemiology of chronic kidney disease and in kidney function methods has gained national attention. He was a grant reviewer for the Centers for Disease Control and Prevention and will moderate a symposium at the American Society of Nephrology Renal Week (2006). The environment will consist of Mayo Clinic - Rochester, where he will have a joint appointment in Nephrology and Epidemiology. His sponsor, Stephen Turner, M.D., Professor of Medicine, will provide him with access to data and train him to be an independent investigator. His mentorship team will also include two Professors of Epidemiology, an Associate Professor of Biostatistics, and the Co-director of the Renal Function Laboratory where 5500 'gold-standard' kidney function measurements are performed annually. The project will compare kidney function measurements between a gold standard method (iothalamate clearance) and more convenient, but potentially less accurate methods, used in clinical practice and in most studies (serum creatinine, cystatin C, estimating equations, and creatinine clearance). The unique feature of this project will be to compare these kidney function methods in community-based samples (mentor's cohort and candidate's cohort). The effect of the kidney function measurement method on coronary artery calcification and risk factor associations with chronic kidney disease will be determined. Relevence: In the United States, 8 million adults have moderate-to-severe reductions in kidney function and are at risk for costly morbid interventions (dialysis or transplantation) and cardiovascular disease. Validation of kidney function methods is needed to identify chronic kidney disease at an earlier stage, characterize its risk factors, and develop new treatment strategies.

描述（由申请人提供）：

项目成果

期刊论文数量（12）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

The association between age and nephrosclerosis on renal biopsy among healthy adults.

DOI：
10.7326/0003-4819-152-9-201005040-00006
发表时间：
2010-05-04
期刊：
Annals of internal medicine
影响因子：
39.2
作者：
Rule AD;Amer H;Cornell LD;Taler SJ;Cosio FG;Kremers WK;Textor SC;Stegall MD
通讯作者：
Stegall MD

Can we do better than a single estimated GFR threshold when screening for chronic kidney disease?

在筛查慢性肾脏病时，我们能否比单一估计的 GFR 阈值做得更好？

DOI：
10.1038/sj.ki.5002452
发表时间：
2007
期刊：
Kidney international
影响因子：
19.6
作者：
Poggio,ED;Rule,AD
通讯作者：
Rule,AD

Eprodisate slows the progression of renal disease in patients with AA amyloidosis.

依普罗地酯可减缓 AA 淀粉样变性患者肾脏疾病的进展。

DOI：
10.1038/ncpneph0615
发表时间：
2007
期刊：
Nature clinical practice. Nephrology
影响因子：
0
作者：
Rule,AndrewD;Leung,Nelson
通讯作者：
Leung,Nelson

Prevalence of CKD in the United States: GFR-estimating equations matter.

美国 CKD 的患病率：GFR 估计方程很重要。

DOI：
10.1053/j.ajkd.2009.02.020
发表时间：
2009
期刊：
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子：
0
作者：
Rule,AndrewD;Turner,StephenT
通讯作者：
Turner,StephenT

The estimated glomerular filtration rate as a test for chronic kidney disease: problems and solutions.

估计肾小球滤过率作为慢性肾脏疾病的测试：问题和解决方案。